Showing 2031-2040 of 3440 results for "".
Redefining the Discourse: Psoriasis in Diverse Skin Tones
https://practicaldermatology.com/topics/psoriasis/redefining-the-discourse-psoriasis-in-diverse-skin-tones/23856/A lack of representation for underserved ethno-racial groups in clinical data and research is an underlying factor contributing to physicians’ challenges with effectively diagnosing and treating psoriasis in patients with diverse skin tones.Currents: PsO Many Options
https://practicaldermatology.com/topics/psoriasis/currents-pso-many-options/23211/Guidelines to Represent Your Dermatology Practice on Google My Business
https://practicaldermatology.com/topics/practice-management/guidelines-to-represent-your-dermatology-practice-on-google-my-business/20837/Google My Business is a powerful tool to reach out to and engage with your target audience online.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21123/Psoriasis and the Metabolic Syndrome
https://practicaldermatology.com/topics/psoriasis/psoriasis-and-the-metabolic-syndrome/21535/Growing data support the notion that TNF inhibitors may decrease various risk factors for the metabolic syndrome.Examining the Implications of Stage 2 of the EHR Incentive Program
https://practicaldermatology.com/topics/practice-management/examining-the-implications-of-stage-2-of-the-ehr-incentive-program/21564/Requirements for patient involvement via portals may spell headaches for physicians hoping to qualify for government incentives in 2014.Harnessing Mobile Technology in Concert with EHRs
https://practicaldermatology.com/topics/practice-management/harnessing-mobile-technology-in-concert-with-ehrs/21637/Significant developments are on the way, but already EHRs offer unique abilities via mobile and tablet technologies.Dermatology Q&A: First Head-to-Head Data Highlight Safety and Efficacy of Biologics
https://practicaldermatology.com/topics/psoriasis/first-head-to-head-data-highlight-safety-and-efficacy-of-biologics/22032/A lead investigator on the first head-to-head trial of biologics shares insights on the future of biologic research and therapy.A Case of Pemphigus Foliaceus
https://practicaldermatology.com/topics/infections-infectious-disease/a-case-of-pemphigus-foliaceus/23156/A case-based discussion of an immunobullous disorder.Open Payments Program: Does it Enhance Open Discussion About Financial Ties Between Dermatologists and Industry?
https://practicaldermatology.com/youngmd-connect/resident-resource-center/open-payments-program-does-it-enhance-open-discussion-about-financial-ties-between-dermatologists-and-industry/23619/The majority of physicians practicing in the United States have received some form of compensation from private industry during their careers. These payments may include consulting fees, compensation for speaking engagements, and stock options. Certain payments take indirect forms, such as physic